AIDOT’s ‘CERVIRAY AI’ Showcased at the 2025 Korean Society of Gynecologic Oncology (KSGO) KU Medicine Department of Obstetric

AIDOT Co., Ltd. (CEO: Jaehoon Jung), a leader in AI-based medical solutions, announced that it presented its AI-powered cervical cancer diagnostic solution, ‘CERVIRAY AI’, at the Department of Obstetrics and Gynecology seminar hosted by the Korean Society of Gynecologic Oncology in 2025 at Korea University College of Medicine.

This seminar was held on August 17, 2025 (Sunday) at Yoo Kwangsa Hall in Korea University Anam Hospital and served as a venue for OB-GYN and gynecologic oncology medical professionals to share the latest clinical insights and innovative diagnostic technologies.

At the event, AIDOT showcased clinical case studies and conducted live demonstrations of ‘CERVIRAY AI’, introducing medical professionals to the accuracy and efficiency of AI-powered automated cervical image interpretation.

Particularly, ‘CERVIRAY AI’ has recently been adopted by numerous domestic and international hospitals, where it is credited with reducing diagnosis time for clinicians and providing more consistent examination results, leading to a paradigm shift in gynecological diagnostics.

Jaehoon Jung, CEO of AIDOT, said, “Participating in this seminar was a meaningful opportunity to foster close collaboration with OB-GYN and gynecologic oncology professionals, as well as to actively promote the real-world clinical benefits of AI-based cervical cancer diagnosis.”

Meanwhile, AIDOT’s CERVIRAY AI is an artificial intelligence solution that assists rapid and precise interpretation by applying AI to conventional visual inspection with acetic acid (VIA) exams. Moving forward, AIDOT aims to continue driving healthcare innovation through participation in various domestic and international conferences and on-site medical education programs.

Korea Economic TV / August 19, 2025 / Deputy General Manager, Jaejoon Yang

Exhibitor Data Sheet